{"count": 3, "results": [{"_id": "1566223", "pmid": 1566223, "title": "Atenolol and visual loss.", "journal": "S Afr Med J", "authors": ["Volmink J"], "date": "1992-04-18T00:00:00Z", "meta_date_publication": "1992 Apr 18", "meta_volume": "81", "meta_issue": "8", "meta_pages": "433", "score": 50097.24, "text_hl": "@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ and @<m>DISEASE_Vision_Disorders</m> @DISEASE_MESH:D014786 @@@visual loss@@@.", "citations": {"NLM": "Volmink J. Atenolol and visual loss. S Afr Med J. 1992 Apr 18;81(8):433. PMID: 1566223", "BibTeX": "@article{1566223, title={Atenolol and visual loss.}, author={Volmink J}, journal={S Afr Med J}, volume={81}, number={8}, pages={433}}"}}, {"_id": "2334086", "pmid": 2334086, "title": "Visual symptoms after atenolol therapy for migraine.", "journal": "Ann Intern Med", "authors": ["Kumar KL", "Cooney TG"], "date": "1990-05-01T00:00:00Z", "doi": "10.7326/0003-4819-112-9-712_2", "meta_date_publication": "1990 May 1", "meta_volume": "112", "meta_issue": "9", "meta_pages": "712-3", "score": 50083.74, "text_hl": "@<m>DISEASE_Vision_Disorders</m> @DISEASE_MESH:D014786 @@@Visual symptoms@@@ after @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ therapy for @DISEASE_Migraine_Disorders @DISEASE_MESH:D008881 @@@migraine@@@.", "citations": {"NLM": "Kumar KL, Cooney TG. Visual symptoms after atenolol therapy for migraine. Ann Intern Med. 1990 May 1;112(9):712-3. PMID: 2334086", "BibTeX": "@article{2334086, title={Visual symptoms after atenolol therapy for migraine.}, author={Kumar KL and Cooney TG}, journal={Ann Intern Med}, volume={112}, number={9}, pages={712-3}}"}}, {"_id": "20436734", "pmid": 20436734, "pmcid": "PMC2859479", "title": "Pseudopheochromocytoma: An uncommon cause of malignant hypertension", "journal": "Indian J Nephrol", "authors": ["Seck SM", "Ka EF", "Niang A", "Diouf B"], "date": "2009-07-01T00:00:00Z", "doi": "10.4103/0971-4065.57111", "meta_date_publication": "2009 Jul", "meta_volume": "19", "meta_issue": "3", "meta_pages": "122-4", "score": 50038.797, "text_hl": "Two months later, we reduced @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ to 50 mg/day to prevent @DISEASE_Hypotension @DISEASE_MESH:D007022 @@@hypotension@@@ episodes and he had a stable blood pressure within normal ranges even after exercise.", "citations": {"NLM": "Seck SM, Ka EF, Niang A, Diouf B. Pseudopheochromocytoma: An uncommon cause of malignant hypertension Indian J Nephrol. 2009 Jul;19(3):122-4. PMID: 20436734", "BibTeX": "@article{20436734, title={Pseudopheochromocytoma: An uncommon cause of malignant hypertension}, author={Seck SM and Ka EF and Niang A and Diouf B}, journal={Indian J Nephrol}, volume={19}, number={3}, pages={122-4}}"}}]}